Gitnux/Report 2026

Aesthetic Surgery Industry Statistics

Women made up 86.1% of global aesthetic surgical procedures in 2022, yet the demand is spreading wider with men reaching 13.9% of worldwide surgery and repeat patients driving 40% of U.S. clientele. From U.S. spending of $13.3 billion in 2022 to a projected 10.9% CAGR for the global aesthetic surgery market through 2030, these figures track who is choosing what, what it costs, and how quickly the market is reshaping.
288Statistics
63Sources
12Sections
1Visuals
49mRead
November 10, 2026Updated
Aesthetic Surgery Industry Statistics
Diana ReevesWritten by Diana Reeves·Fact-checked by Sarah Mitchell
Published ·Updated
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 39 days

01 Industry overview

The aesthetic surgery industry at a glance

The aesthetic surgery industry is expanding rapidly: the global aesthetic surgery procedures market was valued at $73.62 billion in 2025, while surgical procedure volumes continued to rise in major markets.

$73.62B[50]
Global market size, 2025
13.12%[50]
Forecast CAGR, 2026–2034
17.4M[20]
Global surgical procedures, 2024
39%[50]
North America market share, 2025
Market size
The global aesthetic surgery procedures market was valued at $73.62 billion in 2025 and is projected to reach $83.28 billion in 2026. Separately, ISAPS recorded 17,415,678 surgical aesthetic procedures performed by plastic surgeons worldwide in 2024.[50][20]
Forecast & CAGR
Fortune Business Insights forecasts the global market to reach $223.23 billion by 2034, implying a 13.12% CAGR from 2026 to 2034. Grand View Research estimates a lower 12.0% CAGR from 2026 to 2033, reflecting differences in market definitions and methodology.[50][51]
Market share & regions
North America accounted for 39% of global aesthetic surgery procedures market revenue in 2025, followed by Europe at 28% and Asia-Pacific at 24%. Asia-Pacific is identified as the fastest-growing regional market in the forecast period.[50]
Segmentation
Face and head procedures represented approximately 62% of the market by procedure type in 2025, while cosmetic surgery clinics accounted for approximately 68% by end use. ISAPS recorded 7.4 million face and head procedures in 2024, up 4.3% year over year.[50][20]
Key players & concentration
The market includes device, implant, injectable and clinic businesses, including AbbVie, Galderma, Establishment Labs, Johnson & Johnson MedTech’s Mentor, Sientra and GC Aesthetics. Available industry analyses describe the provider market as fragmented, with cosmetic surgery clinics generating more than 60% of market revenue in one 2025 estimate.[51]
Trends, drivers & challenges
Demand is shifting toward facial rejuvenation, lift procedures and post-weight-loss body contouring. In the United States, ASPS reported 7% growth in cosmetic surgical procedures in 2025, while 82% of member surgeons received consultation requests related to GLP-1 use; the report cautions that consultations do not establish completed-procedure growth.[52]
Consumer behavior & competition
ISAPS recorded 37,951,364 global aesthetic procedures in 2024, comprising 17,415,678 surgical and 20,535,686 non-surgical procedures. Eyelid surgery was the leading surgical procedure at 2,115,360 cases, while botulinum toxin was the leading non-surgical procedure at 7,887,955 cases.[20]
M&A
Aesthetic services remain a fragmented market attracting private-equity-backed platforms and add-on acquisitions. The American Med Spa Association reported continued 2025 transaction activity involving platforms including Empower Aesthetics, Alpha Aesthetics, Advanced MedAesthetic Partners and Well Labs+.[38]
Regulation
Regulatory oversight is tightening around injectable products and implants. In November 2025, the U.S. FDA issued 18 warning letters to websites marketing unapproved or misbranded botulinum toxin products, while breast implants remain restricted devices subject to specific approval and risk-communication requirements.[53]
Latest news
The latest major industry statistics indicate continued growth in U.S. surgical demand: ASPS reported 1,523,330 cosmetic surgical procedures in 2025, up 7% from 1,425,390 in 2024. Facial fat grafting grew 39%, eyelid surgery 19% and facelift procedures 13%.[52]

02 Ranking

Top 10 Companies in the Aesthetic Surgery Industry

The leading companies in the aesthetic surgery industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 10, 2026 · Next review December 10, 2026

Verdict

AbbVie leads Gitnux's 2026 aesthetic surgery ranking with an Overall score of 9.6, with 8.57% revenue growth and 24.65% operating margin across Allergan Aesthetics. Merz Aesthetics is the highest-ranked aesthetic skincare provider at 9.3, driven by its injectables, ultrasound devices, and skincare portfolio for aesthetic medicine.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in implants for surgery

    AbbVie

    US

    Ranked #1 · 9.6 · Implants for surgery

    Why we picked it: It sells injectables plus implants and devices, with 2025 Aesthetics performance tied to scale signals.

    See in ranking ↓Visit abbvie.com ↗

  2. Leader in skincare products

    Merz Aesthetics

    DE

    Ranked #2 · 9.3 · Skincare products

    Why we picked it: It spans injectables and devices alongside skincare, covering multiple treatment modalities.

    See in ranking ↓Visit merzaesthetics.com ↗

  3. Leader in aesthetic injectables

    Galderma

    CH

    Ranked #3 · 9.3 · Aesthetic injectables

    Why we picked it: Its injectable-aesthetics business shows double-digit 2025 growth within a dermatology-led lineup.

    See in ranking ↓Visit galderma.com ↗

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the aesthetic surgery industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

AbbVie

Implants for surgery · US

9.6
2

Merz Aesthetics

Skincare products · DE

9.3
3

Galderma

Aesthetic injectables · CH

9.3
4

Johnson & Johnson

Implants for surgery · US

9.2
5

Ipsen

Aesthetic injectables · FR

9.0
6

Sisram Medical

Energy-based medical aesthetic devices · IL

8.3
7

POLYTECH Health & Aesthetics

Breast and body-contouring implants · DE

8.2
8

Bausch Health

Solta laser, RF and skin-tightening devices · CA

8.1
9

Evolus

Jeuveau neuromodulator and injectable fillers · US

8.0
10

Medytox

Botulinum toxin and aesthetic injectables · KR

8.0

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 10, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Diana Reeves. (2026, February 13). Top 10 companies in the aesthetic surgery industry. In Aesthetic Surgery Industry Statistics. Gitnux. https://gitnux.org/aesthetic-surgery-industry-statistics/#top-companies

report visual · Comparison

Global surgical aesthetic procedures by procedure type

Eyelid Surgery leads with 2.1M.

Eyelid Surgery2.1M
Liposuction2.1M
Breast Augmentation1.7M
Scar Revision1.2M
Rhinoplasty1.1M
Abdominoplasty1.0M
source-verifiedisaps.org

04 Statistics

Technology & Innovation

The 2026 technology review quantifies AI, robotics, and augmented-reality study coverage. It also reports EHR-linked predictive AI use in 71% of U.S. acute care hospitals in 2024.

AI in the aesthetic surgery industry

  • 102 physicians participated in a 2026 cross-sectional study of AI adoption in aesthetic practice.[1]
  • 460 qualifying plastic-surgery AI publications were identified from literature published before September 22, 2025.[2]
  • 33 of 55 eligible studies, or 60%, applied AI-based image analysis in aesthetic medicine and surgery worldwide.[3]
  • 12,316 studies were screened and 55 met eligibility criteria for AI, augmented reality or robotics in aesthetic procedures worldwide, covering 2009–2025.[3]
  • 5 of 55 eligible studies, or 9.1%, examined AI-driven risk assessment and outcome prediction in aesthetic procedures worldwide.[3]
  • AI performance expectancy and ease of use together explained 52% of the variance in adoption intention among aesthetic-practice physicians in 2026.[1]

Automation in the aesthetic surgery industry

  • 9 of 55 eligible studies, or 16%, examined robotics in aesthetic medicine and surgery worldwide, covering 2009–2025.[3]
  • 8 of 55 eligible studies, or 15%, examined augmented-reality applications such as intraoperative navigation and preoperative simulation in aesthetic procedures worldwide.[3]

Digital Transformation in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[4]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[5]
  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[6]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[7]
  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[7]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[4]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[4]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[4]
  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[4]
  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[4]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[4]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[8]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 65% used patient demographics, forms, or medical-record data in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 38% used geolocation data from mobile phones, wireless connections, or GPS in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 72% used data from smart devices or sensors in 2024.[9]

IoT in the healthcare services sector (sector benchmark)

  • Among Brazilian private healthcare facilities with internet access, 6% used IoT in 2024.[10]

05 Statistics

Data & Analytics

Operator performance metrics anchor 2026 KPIs, including a 71.0% median 90-day rebooking rate in Q3 2026. The section also flags data-quality issues that affect registry efforts.

Business intelligence in the aesthetic surgery industry

  • 71.0% was the median 90-day rebooking rate tracked by CorralData for aesthetics operators in Q3 2026.[11]
  • $95 was the median blended acquisition cost per new patient reported for aesthetics operators in Q1 2026.[11]
  • 9.7% of GLP-1 patients were new to the practice at the median aesthetics operator in Q3 2026.[11]
  • 35.5% of revenue came from the top 10% of patients at the median aesthetics operator in Q3 2026.[11]
  • 14.3% to 40.7% was the middle-half range for active-patient membership enrollment across aesthetics operators in Q3 2026.[11]
  • 9.0% of revenue came from wellness services at the median aesthetics operator in Q3 2026.[11]

Data analytics in the aesthetic surgery industry

  • 25% was the approximate increase in retention odds associated with each additional scheduled assessment in a multi-clinic aesthetic-practice analysis.[12]
  • 99.6% was the true-match rate at a 0.01% false-match rate for the general facial-plastic-surgery cohort in an automated outcome study.[13]
  • 42.2% was the median share of patients returning from the prior year at aesthetics operators in Q3 2026.[11]
  • 35.5% was the median share of revenue generated by the top 10% of patients at aesthetics operators in Q3 2026.[11]
  • 4.5% of patients in a five-year resident-run facial-injectable clinic experience scheduled a surgical consultation with the chief resident after an encounter.[14]
  • 52.6% of patients in a five-year resident-run facial-injectable clinic experience underwent surgery with the attending after consultation.[14]

Data Quality in the healthcare services sector (sector benchmark)

  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[15]
  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[16]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[16]
  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[16]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[16]

Data Governance in the healthcare services sector (sector benchmark)

  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[15]
  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[15]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[15]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[15]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[15]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[15]

KPIs in the aesthetic surgery industry

  • 13% was the year-over-year decrease in average new patients acquired per practice in the 2024 United States aesthetics-industry overview.[17]
  • 5% was the year-over-year increase in average spend per patient in the 2024 United States aesthetics-industry overview.[17]
  • $1,471 was average spend per patient in the 2024 United States aesthetics-industry overview.[17]
  • 71.0% was the median 90-day rebooking KPI for aesthetics operators in Q3 2026.[11]
  • 1% was the year-over-year increase in average patient retention in the 2024 United States aesthetics-industry overview.[17]
  • 51% was average patient retention in the 2024 United States aesthetics-industry overview.[17]

06 Statistics

Strategy & Growth

Company-level performance indicators sit alongside clinic-operator visit and acquisition signals. AbbVie’s 2025 Aesthetics revenue is $4.860B, down 5.9% from 2024.

Growth in the aesthetic surgery industry

  • SBC Medical estimated approximately 6.6 million annual customer visits across its clinics and franchisee clinics in 2025.[18]
  • AbbVie’s global Aesthetics revenue was $4.860 billion in 2025, down 5.9% from 2024.[19]
  • The Malaysian operator’s new Selangor and Johor clinics contributed RM6.660 million in aesthetic-medical-services revenue in the fiscal year ended March 31, 2025.[18]
  • AbbVie’s international Aesthetics revenue was $1.870 billion in 2025, compared with $2.014 billion in 2024.[19]
  • SBC Medical had 283 clinic locations, including franchisee clinics, as of December 31, 2025.[18]
  • A Malaysian aesthetic-medical operator increased aesthetic-medical-services revenue 25.7% to RM18.015 million in the fiscal year ended March 31, 2025.[18]

Differentiation in the aesthetic surgery industry

  • AbbVie’s Juvederm Collection generated $993 million worldwide in 2025, including $608 million internationally.[19]
  • Breast augmentation reached 1,658,615 procedures worldwide in 2024.[20]
  • AbbVie’s Botox Cosmetic revenue was $1.504 billion in the United States and $1.098 billion internationally in 2025.[19]
  • Rhinoplasty reached 1,083,631 procedures worldwide in 2024, declining 9.8% from 2023.[20]
  • Botulinum toxin generated 8.8 million procedures worldwide in 2023, making it the most common nonsurgical aesthetic procedure.[20]
  • Eyelid surgery reached 2,115,360 procedures worldwide in 2024, increasing 13.4% from 2023.[20]

Mergers and acquisitions in the aesthetic surgery industry

  • BeautyHealth recorded up to $3.2 million of contingent consideration related to its 2023 Esthetic Medical acquisition.[18]
  • SBC Medical acquired 100% of Aesthetic Healthcare Holdings in Singapore for SGD7.8 million on November 20, 2024.[18]
  • SBC Medical committed an additional $5.0 million contribution to OrangeTwist’s holding company for December 2026.[18]
  • SBC Medical acquired more than 50% of Waqoo’s voting rights in December 2025, making Waqoo a consolidated subsidiary.[18]
  • SBC Medical entered into an agreement in November 2024 to acquire 100% of Aesthetic Healthcare Holdings for approximately US$6.0 million.[18]
  • SBC Medical acquired an approximately 18.2% voting interest in OrangeTwist’s holding company for $20 million on December 29, 2025.[18]

Strategic partnerships in the aesthetic surgery industry

  • SBC Medical estimated approximately 6.6 million annual visits across company and franchisee clinics in 2025.[18]
  • BLEZ Asia operated more than 20 clinics and pharmacies in Thailand under the 2025 consulting arrangement with SBC Medical.[18]
  • SBC Medical stated that it provided management services to franchisee and alliance clinics as part of its expansion model in 2025.[18]
  • SBC Medical entered a consulting agreement with BLEZ Asia in November 2025 to support entry into Thailand and a Bangkok dermatology-focused clinic.[18]
  • A Chinese aesthetic-medical company reported online and offline collaboration with external enterprises as a customer-acquisition strategy beginning in the second quarter of 2022.[18]
  • SBC Medical appointed a medical-strategy advisor in July 2025 to support global expansion, physician training and medical quality.[18]

07 Statistics

People & Workforce

Workforce availability and training gaps show up through remote/hybrid participation and large-language-model education. For example, 94.4% of Canadian plastic-surgery residents reported no education or training in 2025.

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[21]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[22]
  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[21]
  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[21]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[21]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[21]
  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[21]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[22]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[21]

Upskilling in the aesthetic surgery industry

  • 58.3% of Canadian plastic-surgery residents used large language models to explain concepts in 2025.[1]
  • 63.8% of Canadian plastic-surgery residents reported using large language models for plastic-surgery education in 2025.[1]
  • 94.4% of Canadian plastic-surgery residents reported receiving no education or training on large-language-model use in 2025.[1]
  • 33.3% of Canadian plastic-surgery residents used large language models to explain procedures in 2025.[1]
  • 36 Canadian plastic-surgery residents responded to a national survey on large-language-model use in postgraduate training in 2025.[1]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[23]
  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[23]
  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[24]
  • Across U.S. healthcare workers, 78% believed their organization cared about their safety in 2024.[23]
  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[23]

Change Management in the healthcare services sector (sector benchmark)

  • Across 36 healthcare transformation studies, 64% reported successful transformation, 6% reported partial success, and 17% reported unsuccessful transformation.[25]
  • Among United Kingdom healthcare transformation studies, 67% reported successful transformation.[25]
  • Among U.S. healthcare transformation studies, 88% reported successful transformation.[25]
  • Across healthcare transformation studies using staff surveys, 78% reported successful transformation and 83% reported either success or partial success.[25]
  • Among Canadian healthcare transformation studies, 40% reported successful transformation and 60% reported either success or partial success.[25]

08 Statistics

Customer & Sales

Demand capture is quantified through retention, rebooking, and churn. In Q3 2026, 71.0% of aesthetic patients were rebooked within 90 days, with a 44.6% median patient-churn rate.

Customer experience in the aesthetic surgery industry

  • 2.5% of aesthetic-surgery patients reported feeling bad or very bad about their body during sex three months after surgery, versus 17.7% before surgery, in a Cyprus study.[1]
  • 38.6% of aesthetic-surgery patients reported being very satisfied with their physical appearance three months after surgery, versus 7.3% before surgery, in a Cyprus clinic study.[1]
  • 16.7% of complaints in a non-surgical aesthetic clinic study concerned billing processes, while 14.3% concerned scheduling issues.[26]
  • 22.3% of complaints in a non-surgical aesthetic clinic study concerned rude staff or bad customer service, making it the largest complaint category.[26]

Customer retention in the aesthetic surgery industry

  • 45.2% of new aesthetic patients returned within 60 days in the third quarter of 2026, based on a benchmark of aesthetics operators.[11]
  • 44.6% was the median patient-churn rate among aesthetics operators in the third quarter of 2026, according to CorralData Research.[11]
  • 42.2% of aesthetic patients returned from the prior year in the third quarter of 2026, based on a benchmark of aesthetics operators.[11]
  • 71.0% of aesthetic patients were rebooked within 90 days in the third quarter of 2026, based on a benchmark of aesthetics operators.[11]

Customer acquisition in the aesthetic surgery industry

  • 14.2% of surveyed social-media users said the number of posts and followers most influenced their choice of a plastic surgeon.[12]
  • 44.3% of respondents who viewed plastic-surgery content on social media did so to learn more about a specific procedure they were interested in having.[12]
  • 74.3% of private-practice plastic surgeons used social media for patient acquisition, compared with 28.3% of salaried surgeons, in a survey study.[2]
  • 48.4% of respondents had viewed plastic-surgery content on social media in a survey of public preferences.[12]
  • 45.9% of surveyed social-media users said before-and-after results most influenced their choice of a plastic surgeon.[12]

Customer loyalty in the aesthetic surgery industry

  • 61.0% of aesthetic patients visited only once during the third quarter of 2026, based on median operator data.[11]
  • 68% of patients enrolled in an aesthetic loyalty program returned for treatment, compared with 42% of non-members, according to a 2026 industry analysis.[27]
  • 50.1% of aesthetic-operator revenue came from existing high-value patients in the third quarter of 2026, based on median operator data.[11]
  • 1.62 visits per patient was the median visit frequency among aesthetics operators in the third quarter of 2026.[11]
  • 35.5% of aesthetic-operator revenue came from the top 10% of patients in the third quarter of 2026, based on median operator data.[11]

Lead generation in the aesthetic surgery industry

  • 11% of surveyed young U.S. plastic surgeons posted on social media multiple times per day.[12]
  • 37% of surveyed young U.S. plastic surgeons posted on social media several times a week.[12]
  • 73% of surveyed young U.S. plastic surgeons used online content about their surgical procedures and techniques.[12]
  • 16% of surveyed young U.S. plastic surgeons posted on social media daily.[12]
  • 60% of surveyed young U.S. plastic surgeons used social-media platforms for marketing or practice promotion.[12]

09 Statistics

Marketing & Brand

Social channels are measured via share of content types and surgeon usage rates. An analysis found 64.5% of posts by the 10 most-followed global plastic surgeons were categorized as marketing content in 2022.

Marketing in the aesthetic surgery industry

  • 64.5% of posts by the 10 most-followed global plastic surgeons were categorized as marketing content in a 2022 Instagram analysis.[12]
  • 650,000 was the average Instagram follower count among the 10 most-followed plastic surgeons analyzed in 2022.[12]
  • 21% growth in new-patient volume followed a professional rebranding initiative at a plastic-surgery practice, according to a case reported in 2026.[12]
  • 4.5% of posts by the 10 most-followed global plastic surgeons were categorized as educational content in a 2022 Instagram analysis.[12]
  • 38% of plastic-surgery-related Instagram posts were authored by board-certified plastic surgeons in an analysis of 700,000 posts.[12]

Digital marketing in the aesthetic surgery industry

  • 5% of surveyed young U.S. plastic surgeons selected YouTube, IGTV or Twitter as their primary electronic-marketing platform.[12]
  • 29% of surveyed young U.S. plastic surgeons primarily used Instagram for electronic marketing, while 27% primarily used Facebook.[12]
  • 33.8% of American Society of Plastic Surgeons members reported a positive practice impact from social media in a 2022 survey.[12]
  • 70% of surveyed young U.S. plastic surgeons used a personal or practice website in their electronic-marketing activity.[12]
  • 61.9% of surveyed plastic surgeons reported having an active professional social-media account in a cited member survey.[12]

Branding in the aesthetic surgery industry

  • More than 50% of surveyed young U.S. plastic surgeons marketed practice-branding information, according to a study of electronic practice marketing.[12]
  • 74% of surveyed young U.S. plastic surgeons marketed bio or personal information about themselves, a core surgeon-branding content type.[12]
  • 32% of surveyed plastic-surgery social-media users selected incorporation into practice as inevitable as a reason for use.[3]
  • 61% of private-practice plastic surgeons used social media for practice branding, compared with 21.7% of salaried surgeons, in a survey study.[2]
  • 49% of surveyed plastic-surgery social-media users cited patient education as a reason for using social media.[3]

Social media in the aesthetic surgery industry

  • 9.7% was the median Instagram engagement rate for academic plastic surgeons in Ontario, compared with 0.8% for community surgeons.[12]
  • 45.9% of surveyed respondents rated before-and-after results as the most influential social-media account feature when selecting a plastic surgeon.[12]
  • 4.9% was the median engagement rate for personal Instagram posts by Ontario plastic surgeons.[12]
  • 27.2% of surveyed respondents preferred video posts for plastic-surgery social-media content.[12]
  • 51.4% of surveyed respondents preferred photo posts for plastic-surgery social-media content.[12]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[28]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[29]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[28]
  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[30]
  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[31]

10 Statistics

Operations & Execution

Operational throughput and workflow allocation are quantified, including OR turnover time and direct care time shares. The section reports 22.6 minutes average operating-room turnover time for plastic surgery cases in 2024.

Process optimization in the aesthetic surgery industry

  • 67.43% of surgeon clinic time was spent in direct patient care with the conventional single-room workflow in the same outpatient plastic-surgery study.[1]
  • 22.6 minutes was the average operating-room turnover time for plastic surgery cases in 2024 across surveyed U.S. ambulatory surgery centers.[32]
  • 95.15% of surgeon clinic time was spent in direct patient care when two minor procedure rooms were used in an outpatient plastic-surgery workflow.[1]
  • 5 of 6 plastic-surgery lean-methodology studies reporting cost outcomes found increased savings, while 1 reported no change.[12]
  • 32.57% of surgeon clinic time was spent outside direct patient care with the conventional workflow, versus 4.85% using two minor procedure rooms.[1]

Operational efficiency in the aesthetic surgery industry

  • 22.6 minutes was the reported average plastic-surgery operating-room turnover time in 2024.[32]
  • 95.15% of surgeon clinic time was devoted to direct patient care with two parallel minor procedure rooms in outpatient plastic surgery.[1]
  • 67.43% of surgeon clinic time was devoted to direct patient care with the conventional minor-procedure-room arrangement.[1]
  • 4.85% of surgeon clinic time was spent outside direct patient care with two minor procedure rooms, compared with 32.57% under the conventional setup.[1]

Quality management in the aesthetic surgery industry

  • 22.5% of patients treated for aesthetic-surgery complications at a tertiary center had wound dehiscence in the 2024 series.[1]
  • 0.74% was the overall complication rate among 42,720 consecutive outpatient plastic-surgery cases performed from 1995 through 2023.[33]
  • 32.5% of patients treated for aesthetic-surgery complications at a tertiary center had infection, the most common complication in the 2024 series.[1]
  • 50% of patients evaluated for aesthetic-surgery complications at a tertiary center required inpatient admission in the 2024 series.[1]
  • 2.2% was the complication rate per procedure in a 2020–2024 review of 4,244 medical-tourism plastic-surgery procedures.[12]

Supply chain in the aesthetic surgery industry

  • 2,720 million USD was AbbVie’s 2024 Botox Cosmetic revenue, while Juvéderm Collection generated 1,177 million USD.[19]
  • 1,285 million USD was Galderma’s 2024 neuromodulator revenue, representing 10.6% reported growth from 2023.[34]
  • 2,299 million USD was Galderma’s 2024 injectable-aesthetics revenue, up 8.0% on a reported basis from 2023.[34]
  • 1,014 million USD was Galderma’s 2024 fillers-and-biostimulators revenue, up 5.0% on a reported basis from 2023.[34]
  • 2,128 million USD was Galderma’s 2023 injectable-aesthetics revenue before it increased to 2,299 million USD in 2024.[34]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 18% of U.S. medical-group leaders planned to outsource or automate patient communications in contact centers in 2024, according to an MGMA poll with 262 responses.[21]
  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[35]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[35]

11 Statistics

Finance & Pricing

Price benchmarks and margin ranges support scenario planning for procedures. The 2024 U.S. price benchmark for implant-based breast augmentation is $4,575–$8,000.

Pricing strategy in the aesthetic surgery industry

  • 8,000–13,500 USD was the 2024 U.S. price benchmark for abdominoplasty.[12]
  • 3,000–5,500 USD was the 2024 U.S. price benchmark for upper blepharoplasty.[12]
  • 6,500–11,000 USD was the 2024 U.S. price benchmark for breast lift surgery.[12]
  • 7,500–12,500 USD was the 2024 U.S. price benchmark for rhinoplasty.[12]
  • 4,575–8,000 USD was the 2024 U.S. price benchmark for implant-based breast augmentation.[12]

Cost reduction in the aesthetic surgery industry

  • 1 of 5 plastic-surgery lean studies measuring patient satisfaction reported no change after lean interventions.[12]
  • 5 of 6 plastic-surgery lean studies reporting cost outcomes found increased savings after lean-methodology implementation.[12]
  • 20–21 USD per operating-room minute was the estimated direct cost cited for financial analysis of facial plastic surgery.[12]
  • 4 of 5 plastic-surgery lean studies measuring patient satisfaction reported improvement after lean interventions.[12]
  • 5 of 5 plastic-surgery lean studies measuring hospital length of stay reported reductions after lean interventions.[12]

Profitability in the aesthetic surgery industry

  • 1,031 million USD was Galderma’s 2024 core EBITDA, on net sales of 4,410 million USD.[34]
  • 39.1% was the 2024 gross-profit margin for the direct-store beauty-and-wellness service segment of a listed Chinese aesthetics company.[36]
  • 46.7% was the 2024 gross-profit margin for the premium AI-powered wellness service acquired by the same listed beauty-and-wellness company.[36]
  • 20–40% was the reported operating-income-margin range for aesthetic medical practices, depending on specialty.[37]
  • 5:1 was the reported benchmark debt-to-equity ratio for aesthetic practices in a financial-business review.[37]

Financial planning in the aesthetic surgery industry

  • 2:1 was the minimum current-ratio level recommended for aesthetic practices in a financial-business review.[37]
  • 2–6% of total revenue was the reported planning range for rent expense in aesthetic practices.[37]
  • 5:1 was described as the ideal current ratio for an aesthetic practice seeking stronger liquidity.[37]
  • 60% was the gross-profit margin example used by the American Med Spa Association to illustrate treatment-level financial planning.[38]
  • 5:1 was the reported debt-to-equity benchmark for aesthetic practices planning growth through borrowing.[37]

12 Statistics

Product & Service

The section compiles regulatory recall rates and tech-investment volumes. It reports 6.2% of 3,194 plastic-surgery devices cleared via FDA 510(k) from 2008–2023 were recalled in the U.S.

Product development in the aesthetic surgery industry

  • More than 4,600 patents were awarded for plastic-surgery innovations including injectables, prostheses, implants and tissue engineering between 1960 and 2010.[12]
  • 402 venture-capital investments in plastic and aesthetic surgery companies were recorded globally between 2003 and 2023.[12]
  • $487.9 million, or 25.3% of plastic-surgery venture investment, targeted surgical software from 2003 to 2023.[12]
  • $1.98 billion was invested in 163 plastic and aesthetic surgery companies by 543 venture-capital firms from 2003 to 2023 worldwide.[12]
  • $523 million, or 26.5% of plastic-surgery venture investment, targeted facial cosmetic surgery from 2003 to 2023.[12]

Product lifecycle in the aesthetic surgery industry

  • 4.1% of laser-and-energy devices cleared through the FDA 510(k) pathway from 2008 to 2023 were recalled in the United States.[14]
  • 6.2% of 3,194 plastic-surgery devices cleared through the FDA 510(k) pathway from 2008 to 2023 were recalled in the United States.[14]
  • 0.3% of plastic-surgery devices cleared through the FDA 510(k) pathway from 2008 to 2023 received a Class I recall in the United States.[14]
  • 14.6% of implant-and-fixation devices cleared through the FDA 510(k) pathway from 2008 to 2023 were recalled in the United States.[14]
  • 8.7% of wound-closure devices cleared through the FDA 510(k) pathway from 2008 to 2023 were recalled in the United States.[14]

After-sales in the aesthetic surgery industry

  • 71.0% of completed appointments at the median aesthetics operator led to another booking within 90 days in Q3 2026.[11]
  • 1.7 times as much was spent by membership patients as by non-members at the median aesthetics operator in Q3 2026.[11]
  • $1,628 was the median patient lifetime value at aesthetics operators in Q3 2026.[11]
  • 45.2% of new patients at the median aesthetics operator returned within 60 days in Q3 2026.[11]
  • 42.2% of patients at the median aesthetics operator had returned from the prior year in Q3 2026.[11]

Value proposition in the aesthetic surgery industry

  • $469 million was AbbVie’s 2024 United States Juvederm Collection revenue.[19]
  • $1.038 billion was AbbVie’s 2024 international Botox Cosmetic revenue.[19]
  • $708 million was AbbVie’s 2024 international Juvederm Collection revenue.[19]
  • $1.682 billion was AbbVie’s 2024 United States Botox Cosmetic revenue.[19]
  • $1.177 billion was AbbVie’s 2024 global Juvederm Collection revenue across the United States and international markets.[19]

13 Statistics

Sustainability & Ethics

Sustainability tradeoffs appear through surgeon willingness to switch practices and measured waste and emissions. One rhinoplasty procedure is reported at 16.99 kgCO2e in a review published before 2025.

Sustainability in the aesthetic surgery industry

  • 7.7% of surveyed surgeons could estimate the carbon footprint of a surgical procedure, international survey, 2024.[12]
  • 75% of 1,017 surveyed surgeons were willing to switch from single-use to reusable gowns, international survey, 2024.[12]
  • 56% of 79 oculofacial plastic surgeons had already changed their practice to increase sustainability, United States, 2026.[39]
  • 70% of 1,017 surveyed surgeons were willing to switch from first-time-use instruments to reprocessed instruments, international survey, 2024.[12]
  • 67% of 1,017 surveyed surgeons were willing to ask anesthesiologists to switch to a more sustainable anesthetic, international survey, 2024.[12]

Ethics in the aesthetic surgery industry

  • 21% of 57 allegations in plastic-surgery resident malpractice cases concerned lack of informed consent for procedure complications, United States analysis, 2023.[12]
  • 77% of 22 United States plastic-surgery malpractice cases reporting board-certification status involved board-certified surgeons, based on cases through 2017.[1]
  • 8.6% of 2,674 United States plastic-surgery malpractice claims were classified as having high clinical severity, based on claims closed from 2009 to 2018.[1]
  • 26.8% of 2,674 United States plastic-surgery malpractice claims closed between 2009 and 2018 resulted in an indemnity payment.[1]
  • 90% of 165 United States plastic-surgery malpractice cases involved surgeons working in private practice, based on litigation records through 2017.[1]

Circular economy in the aesthetic surgery industry

  • 14% of 2,309 kg of operating-theatre waste was recyclable in an Australian hospital audit, 2025.[40]
  • 5.98 kg of solid waste was generated per operation in an Australian operating-theatre audit, 2025.[40]
  • 230 kg of operating-theatre waste was generated per day in an Australian tertiary hospital audit, 2025.[40]
  • 7.15 kg of waste per case was generated by orthopaedic surgery, the highest specialty-adjusted result in an Australian operating-theatre audit, 2025.[40]
  • 40% of 2,309 kg of operating-theatre waste was general waste in an Australian hospital audit, 2025.[40]

Carbon footprint in the aesthetic surgery industry

  • 16.99 kgCO2e was reported for one rhinoplasty procedure in a plastic-surgery sustainability review, study data published before 2025.[41]
  • 4–814 kgCO2e was the reported range for a single surgical procedure across a systematic review that included plastic and dermatological surgery, 2023.[1]
  • 0.2–4 kg of waste per case was reported across operating-room studies in a systematic review that included plastic and dermatological surgery, 2023.[1]
  • 32.4 kgCO2e was reported for one open carpal-tunnel-release operating-room case in a plastic-surgery sustainability review, study data published before 2025.[41]
  • 23.68 kgCO2e was reported for one abdominoplasty procedure in a plastic-surgery sustainability review, study data published before 2025.[41]

15 Statistics

Globalization & Expansion

International scale comes from ISAPS procedure totals and survey coverage. ISAPS recorded 37,951,364 aesthetic procedures worldwide in 2024.

Globalization in the aesthetic surgery industry

  • More than 15.8 million surgical aesthetic procedures were performed by plastic surgeons worldwide in 2023.[20]
  • The United States performed more than 6.1 million aesthetic procedures in 2023, the highest national total reported by ISAPS.[20]
  • ISAPS collected 2024 data from 2,975 plastic surgeons, compared with 1,600 respondents for its 2023 statistics.[20]
  • Approximately 80% of plastic surgeons worldwide primarily focus on aesthetic procedures, according to the 2024 ISAPS survey.[20]
  • 37,951,364 aesthetic procedures were performed worldwide in 2024, including 17,415,678 surgical procedures and 20,535,686 nonsurgical procedures.[20]

Cultural adaptation in the aesthetic surgery industry

  • Approximately 100 undergraduates per country and study phase participated in a comparison of cosmetic-surgery acceptance in Hong Kong, Japan and the United States.[12]
  • More than 60% of patients in the Ghanaian aesthetic-surgery series were aged 30–39 or 40–49 years in 2025.[48]
  • Five U.S. geographic regions were compared in a study examining regional differences in per-capita plastic surgeons and cosmetic procedures using 2013 data.[12]
  • 62% of aesthetic-surgery patients in a one-year Ghanaian hospital case series underwent Brazilian butt lift procedures in 2025.[48]
  • Fewer than 3% of cases in the Ghanaian aesthetic-surgery series were breast augmentations in 2025.[48]

Supplier management in the aesthetic surgery industry

  • Suneva Medical had maintained a two-year business relationship with the Chinese aesthetic-medical operator by 2025.[49]
  • Aesthetic-medical supplies in 2025 primarily included implants, injection materials, pharmaceuticals, medical consumables and skincare products.[49]
  • Five largest suppliers provided injection materials, implants and medical consumables to a Chinese aesthetic-medical operator in 2025.[49]
  • Suneva became a new supplier to the Hong Kong-listed aesthetic-medical operator in 2024.[36]

Stakeholder management in the aesthetic surgery industry

  • Men’s surgical aesthetic procedures increased 18% in the face-and-head category in 2023, according to ISAPS.[20]
  • 2,975 plastic surgeons contributed data to the ISAPS 2024 international survey, supporting industry-wide stakeholder reporting.[20]
  • Women accounted for 85.5% of total aesthetic procedures reported by ISAPS in 2023.[20]
  • Approximately 58,500 plastic surgeons were estimated worldwide in the 2024 ISAPS methodology, with coverage representing 98% of that estimate.[20]
  • ISAPS’ 2024 survey covered 32 locations individually, compared with 23 locations in the prior report.[20]

Distribution channels in the aesthetic surgery industry

  • A Malaysian aesthetic-medical operator reported RM18.015 million in aesthetic-medical-services revenue for the fiscal year ended March 31, 2025.[18]
  • 31.4% of surgical aesthetic procedures were performed in office facilities worldwide in 2023.[20]
  • 46.9% of surgical aesthetic procedures were performed in hospitals worldwide in 2023.[20]
  • A Chinese aesthetic-medical company generated RMB32.832 million, or 17.3% of total revenue, from aesthetic-medical equipment product sales in 2025.[49]
  • A Chinese aesthetic-medical company generated RMB152.909 million, or 80.7% of total revenue, from aesthetic-medical services in 2025.[49]

Key questions about the Aesthetic Surgery Industry

How large is the aesthetic surgery procedures market in 2025, and what is projected for 2026?
The global aesthetic surgery procedures market was valued at $73.62B in 2025 and is projected to reach $83.28B in 2026.
What is the expected growth rate from 2026 to 2034, and how do forecasts differ?
Fortune Business Insights forecasts a 13.12% CAGR from 2026 to 2034, reaching $223.23B. Grand View Research estimates 12.0% CAGR from 2026 to 2033.
Which companies lead the aesthetic surgery industry?
AbbVie leads Gitnux's 2026 aesthetic surgery ranking with an Overall score of 9.6, with 8.57% revenue growth and 24.65% operating margin across Allergan Aesthetics. Merz Aesthetics is the highest-ranked aesthetic skincare provider at 9.3, driven by its injectables, ultrasound devices, and skincare portfolio for aesthetic medicine.
What technology shifts show up in 2026 analysis for aesthetic practice?
A 2026 review screened 12,316 studies and found 55 eligible technology studies (2009–2025). Of these, 60% applied AI-based image analysis, and 16% examined robotics.
How fragmented is the provider market, and how does end use affect revenue shares?
Industry analyses describe cosmetic surgery clinics as a fragmented provider market, with one 2025 estimate stating clinics generated more than 60% of market revenue. End use is estimated at about 68% for cosmetic surgery clinics.
What do recent U.S. procedural and compliance signals suggest about near-term demand and oversight?
ASPS reported 1,523,330 cosmetic surgical procedures in 2025, up 7% from 1,425,390 in 2024. Regulatory oversight is tightening, including 18 U.S. FDA warning letters in November 2025 for websites marketing unapproved or misbranded botulinum toxin products.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Diana Reeves. (2026, February 13). Aesthetic Surgery Industry Statistics. Gitnux. https://gitnux.org/aesthetic-surgery-industry-statistics
MLA
Diana Reeves. "Aesthetic Surgery Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/aesthetic-surgery-industry-statistics.
Chicago
Diana Reeves. 2026. "Aesthetic Surgery Industry Statistics." Gitnux. https://gitnux.org/aesthetic-surgery-industry-statistics.

Sources & references

63 sources cited across this report

  1. pubmed.ncbi.nlm.nih.gov
  2. doi.org
  3. link.springer.com
  4. healthit.gov
  5. kpmg.com
  6. business.adobe.com
  7. deloitte.com
  8. go.rackspace.com
  9. cetic.br
  10. nic.br
  11. corraldata.com
  12. pmc.ncbi.nlm.nih.gov
  13. arxiv.org
  14. academic.oup.com
  15. intersystems.com
  16. carta.healthcare
  17. qsight.guidepoint.com
  18. sec.gov
  19. investors.abbvie.com
  20. isaps.org
  21. mgma.com
  22. wfhresearch.com
  23. pressganey.com
  24. england.nhs.uk
  25. journals.sagepub.com
  26. medicine.fiu.edu
  27. fractionalaesthetics.com
  28. pewresearch.org
  29. media.sproutsocial.com
  30. brand-news.it
  31. sermo.com
  32. hstpathways.com
  33. dam.assets.ohio.gov
  34. galderma.com
  35. tcs.com
  36. hkexnews.hk
  37. assets.bmctoday.net
  38. americanmedspa.org
  39. aao.org
  40. onlinelibrary.wiley.com
  41. discovery.ucl.ac.uk
  42. ache.org
  43. ponemonsullivanreport.com
  44. proofpoint.com
  45. kff.org
  46. sophos.com
  47. hfmmagazine.com
  48. sciencedirect.com
  49. newsfile.moomoo.com
  50. fortunebusinessinsights.com
  51. grandviewresearch.com
  52. plasticsurgery.org
  53. fda.gov
  54. allerganaesthetics.com
  55. us.merzaesthetics.com
  56. dica.nl
  57. ipsen.com
  58. sisram-medical.com
  59. polytech-health-aesthetics.com
  60. ir.bauschhealth.com
  61. investors.evolus.com
  62. medytox.com
  63. accessdata.fda.gov